Overview
Revenue
$10+ billion (USD) per year
Headquarters
Mumbai, Maharastra
Category
Reaching People. Touching Lives.
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 2,000 scientists and R&D investments of over 7-8% of annual revenues. Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integrated, specialty pharmaceutical Sun Pharmaceutical Industries Limited manufactures and markets pharmaceuticals for domestic and international distribution. The Company's pharmaceutical portfolio includes drugs in the areas of diabetes, cardiology, neurology, psychiatry and gastroenterology. Sun Pharmaceutical Industries Ltd. - Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by . Sun Pharmaceutical Industries is one of India's brightest stars in the pharmaceutical industry. The company develops, makes, and markets generic pharmaceuticals in a variety of dosage forms (oral tablets and capsules, injectables, creams, and nasal sprays). Its products target chronic therapeutic areas including cardiology, gastroenterology, neurology, psychiatry, and orthopedics. Sun Pharma also manufactures active pharmaceutical ingredients (APIs) for other drugmakers. The company markets its products around the globe and has 20 manufacturing plants in the Americas, Asia, and Europe.
